Latest Stories
2 Reasons to Watch CINF and 1 to Stay Cautious
Cincinnati Financial trades at $162.19 per share and has stayed right on track with the overall market, gaining 8.9% over the last six months. At the same time, the S&P 500 has returned 10%.
WisdomTree (WT): Buy, Sell, or Hold Post Q3 Earnings?
Since January 2021, the S&P 500 has delivered a total return of 80.2%. But one standout stock has more than doubled the market - over the past five years, WisdomTree has surged 187% to $15.31 per share. Its momentum hasn’t stopped as it’s also gained 18.4% in the last six months thanks to its solid quarterly results, beating the S&P by 8.4%.
3 Reasons We’re Fans of Lululemon (LULU)
Over the past six months, Lululemon’s stock price fell to $201.69. Shareholders have lost 9.6% of their capital, which is disappointing considering the S&P 500 has climbed by 10%. This might have investors contemplating their next move.
3 Reasons to Sell ADT and 1 Stock to Buy Instead
ADT has been treading water for the past six months, recording a small loss of 2.3% while holding steady at $8.24. The stock also fell short of the S&P 500’s 10% gain during that period.
Clarus (CLAR): Buy, Sell, or Hold Post Q3 Earnings?
Clarus currently trades at $3.74 per share and has shown little upside over the past six months, posting a middling return of 1.4%. The stock also fell short of the S&P 500’s 10% gain during that period.
3 Reasons to Sell FBIN and 1 Stock to Buy Instead
Fortune Brands has had an impressive run over the past six months as its shares have beaten the S&P 500 by 6.2%. The stock now trades at $61.55, marking a 16.2% gain. This performance may have investors wondering how to approach the situation.
3 Reasons to Avoid MSTR and 1 Stock to Buy Instead
Strategy has gotten torched over the last six months - since July 2025, its stock price has dropped 59.1% to $174.27 per share. This may have investors wondering how to approach the situation.
3 Reasons to Sell HDSN and 1 Stock to Buy Instead
Over the past six months, Hudson Technologies’s shares (currently trading at $7.49) have posted a disappointing 7.6% loss, well below the S&P 500’s 10% gain. This may have investors wondering how to approach the situation.
3 Reasons to Avoid MET and 1 Stock to Buy Instead
MetLife has been treading water for the past six months, recording a small return of 0.6% while holding steady at $76.77. The stock also fell short of the S&P 500’s 10% gain during that period.
3 Reasons DHR is Risky and 1 Stock to Buy Instead
Danaher has had an impressive run over the past six months as its shares have beaten the S&P 500 by 15.6%. The stock now trades at $236.20, marking a 25.6% gain. This performance may have investors wondering how to approach the situation.